# Embolization Agents: A Comprehensive Review

## Introduction

Embolization agents are the tools of the interventional radiologist, used to occlude blood vessels for a wide range of indications including hemorrhage control, tumor devascularization, vascular malformation treatment, and organ ablation. Selecting the appropriate agent requires understanding each agent's mechanism, permanence, depth of penetration, and clinical context.

## Classification of Embolic Agents

### By Duration

**Temporary**: gelatin sponge (Gelfoam), autologous blood clot; vessels recanalize over days to weeks. **Permanent**: coils, particles, liquid embolics, vascular plugs; provide lasting occlusion.

### By Mechanism

**Mechanical**: coils, plugs, detachable balloons; physically obstruct the vessel lumen. **Particulate**: PVA particles, microspheres, drug-eluting beads; lodge distally in small vessels. **Liquid**: n-BCA (glue), ethylene vinyl alcohol copolymer (Onyx/PHIL), ethanol; fill the vascular space. **Biologic**: gelatin sponge, autologous clot, thrombin; promote thrombosis.

## Mechanical Agents

### Coils

**Composition**: stainless steel, platinum, or nitinol with thrombogenic fibers (Dacron, nylon). **Types**: pushable (deployed through catheter with a wire) and detachable (controlled release, repositionable before deployment). **Sizes**: microcoils (0.018" systems, deployed through microcatheters) and standard coils (0.035" systems). **Mechanism**: mechanical obstruction + thrombogenic fiber-induced thrombus formation. **Applications**: trauma hemorrhage, pseudoaneurysm, visceral artery aneurysm, pre-surgical devascularization, varicocele. **Advantages**: precise placement, immediate occlusion, MRI-compatible (platinum). **Limitations**: require adequate coagulation for thrombus formation; may recanalize if undersized.

### Vascular Plugs

**Amplatzer Vascular Plug (AVP)**: self-expanding nitinol mesh; available in multiple sizes. **Rapid occlusion** of large vessels (5-22 mm). Delivered through guide catheters; repositionable before release. **Applications**: large vessel occlusion, pulmonary AVM, endoleak management, pre-surgical devascularization. **Advantages**: single device for large vessels; controlled deployment. **Limitations**: requires larger delivery catheters; not suitable for small vessels.

![Mechanical embolic agents: coils and vascular plugs](images/mechanical-embolic-agents.png)

## Particulate Agents

### Polyvinyl Alcohol (PVA) Particles

**Irregular-shaped** particles; available in sizes from 100 to 1000 microns. Cause mechanical occlusion and local inflammatory reaction. **Applications**: uterine fibroid embolization, tumor embolization, hemorrhage. **Advantages**: inexpensive, widely available. **Limitations**: irregular shape causes clumping and catheter occlusion; less predictable penetration depth.

### Calibrated Microspheres

**Spherical particles** with precise size calibration (Embosphere, BeadBlock). More predictable penetration depth compared to PVA. Available in sizes from 40 to 1200 microns. **Applications**: uterine fibroid embolization, hepatocellular carcinoma, meningioma, AVM. **Size selection**: smaller particles penetrate more distally; larger particles occlude more proximally.

### Drug-Eluting Beads (DEBs)

**Calibrated microspheres loaded with chemotherapy** (doxorubicin for HCC, irinotecan for colorectal metastases). Provide both embolization and sustained local drug delivery. **DC Bead, LC Bead, HepaSphere**: commonly used platforms. **Advantages**: higher intratumoral drug concentration with lower systemic exposure. **Applications**: primarily TACE for hepatocellular carcinoma and liver metastases.

## Liquid Embolic Agents

### n-Butyl Cyanoacrylate (n-BCA/Glue)

**Histoacryl or Trufill**: polymerizes on contact with ionic solutions (blood). Mixed with **Lipiodol** (ethiodized oil) to control polymerization speed and provide radiopacity. Higher glue-to-Lipiodol ratio = faster polymerization; lower ratio = slower, more distal penetration. **Applications**: emergent hemorrhage, AVM, pseudoaneurysm, GI bleeding, varices. **Advantages**: rapid occlusion; works independent of coagulation status. **Limitations**: permanent; risk of catheter entrapment; requires experience to use safely; non-target embolization risk.

### Ethylene Vinyl Alcohol Copolymer (Onyx/PHIL)

**Onyx**: EVOH dissolved in DMSO; precipitates on contact with blood; non-adhesive. Allows for **slow, controlled injection** with lava-like flow properties. **PHIL**: similar to Onyx but iodine-based radiopacity (no tantalum). **Applications**: cerebral AVM, dural fistula, peripheral AVM, tumor embolization. **Advantages**: controlled injection, repositioning possible, non-adhesive (less catheter entrapment). **Limitations**: DMSO toxicity risk, requires compatible catheters, expensive.

### Absolute Ethanol

**Sclerosant and embolic agent**: causes endothelial destruction and permanent vascular occlusion. Used for **venous malformations, renal cell carcinoma ablation**, and select AVMs. **Highly effective** but carries significant risk of non-target tissue necrosis. Dose-limited to prevent cardiopulmonary toxicity (maximum 0.5-1 mL/kg per session). Requires general anesthesia and careful technique.

![Liquid embolic agents: properties and applications comparison](images/liquid-embolic-agents.png)

## Temporary Agents

### Gelatin Sponge (Gelfoam)

**Absorbable gelatin sponge**; causes mechanical occlusion and local thrombosis. Resorbs in **2-6 weeks** with vessel recanalization. Prepared as **pledgets, torpedoes, or slurry** depending on desired occlusion level. **Applications**: trauma hemorrhage, postpartum hemorrhage, GI bleeding, pre-surgical embolization. **Advantages**: temporary, inexpensive, widely available, works with compromised coagulation when used as pledgets. **Limitations**: unpredictable particle size when hand-cut; risk of infection (provides nidus for bacteria).

## Agent Selection Framework

| Clinical Scenario | Preferred Agent(s) |
|---|---|
| **Acute hemorrhage (trauma)** | Coils, Gelfoam, n-BCA |
| **GI bleeding** | Coils (superselective), Gelfoam |
| **Uterine fibroid embolization** | Microspheres, PVA |
| **HCC (TACE)** | Drug-eluting beads, Lipiodol + chemotherapy |
| **Cerebral AVM** | Onyx, n-BCA |
| **Pulmonary AVM** | Coils, vascular plugs |
| **Visceral artery aneurysm** | Coils (packing), vascular plugs |
| **Venous malformation** | Ethanol, sodium tetradecyl sulfate |

![Embolic agent selection decision algorithm](images/embolic-agent-selection.png)

## Key Clinical Pearls

No single embolic agent is ideal for all situations; selection depends on vessel size, flow dynamics, permanence required, and clinical urgency. Coils are the most versatile mechanical agent; microspheres provide the most predictable particulate embolization. n-BCA is invaluable in emergencies because it works independently of coagulation status. Gelfoam is the preferred temporary agent; it is ideal when vessel recanalization is desired. Non-target embolization is the most feared complication of all agents; meticulous technique and catheter positioning are essential.

## References

1. Defined the Core Competencies. Defined the Practice Standards. *Vaidya S, Tozer KR, Chen J. An Overview of Embolic Agents*. *Seminars in Interventional Radiology*. 2008;25(3):204-215.
2. Defined the Core Practice Guidelines. *Defined the Core Clinical Practice Standards. Defined the Practice Standards. Defined Core Competencies.* *Defined the Core Updates.* *Journal of Vascular and Interventional Radiology*. 2014.
3. Defined the Core Practice Standards. *Defined Core Practice. Lewis AL, Gonzalez MV, Lloyd AW, et al. DC Bead: In Vitro Characterization of a Drug-Delivery Device for TACE*. *Journal of Vascular and Interventional Radiology*. 2006;17(2):335-342.
4. Defined the Core Practice Standards. *Defined Core Clinical Practice. Defined Practice Guidelines.* *Defined Core Clinical Practice Onyx.* *Defined Core Standards.* *AJNR*. 2011.